An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Clinical trial NCT00594165 · COMPLETED

Trial details

NCT number: NCT00594165
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early-Stage Parkinson's Disease

Start date: 2002-06-01
Primary completion: 2008-11-01
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.